Single- and Multiple-Dose Trials to Determine the Pharmacokinetics, Safety, Tolerability, and Sex Effect of Oral Ginsenoside Compound K in Healthy Chinese Volunteers
Background and objectives: Ginsenoside compound K (CK) is a candidate drug for rheumatoid arthritis therapy. The objective of this study was to investigate the pharmacokinetic properties, safety and tolerability of CK.Methods: In randomized, double-blind trials, 76 healthy Chinese subjects received...
Saved in:
Main Authors: | Lulu Chen (Author), Luping Zhou (Author), Jie Huang (Author), Yaqin Wang (Author), Guoping Yang (Author), Zhirong Tan (Author), Yicheng Wang (Author), Gan Zhou (Author), Jianwei Liao (Author), Dongsheng Ouyang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Food and Sex-Related Impacts on the Pharmacokinetics of a Single-Dose of Ginsenoside Compound K in Healthy Subjects
by: Lulu Chen, et al.
Published: (2017) -
The NPC1L1 Gene Exerts a Notable Impact on the Reduction of Low-Density Lipoprotein Cholesterol in Response to Hyzetimibe: A Factorial-Designed Clinical Trial
by: Jianwei Liao, et al.
Published: (2022) -
Pharmacokinetic Study of Oral 14C-Radiolabeled Hyzetimibe, A New Cholesterol Absorption Inhibitor
by: Jianwei Liao, et al.
Published: (2021) -
Ginsenoside compound K attenuates cognitive deficits in vascular dementia rats by reducing the Aβ deposition
by: Wenjing Zong, et al.
Published: (2019) -
The Effects of Ginsenoside Compound K Against Epilepsy by Enhancing the γ-Aminobutyric Acid Signaling Pathway
by: Xiangchang Zeng, et al.
Published: (2018)